{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:34Z","timestamp":1786119634626,"version":"build-2736575974"},"reference-count":76,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1097\/med.0b013e32830eb8ab","type":"journal-article","created":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T01:55:38Z","timestamp":1294970138000},"page":"446-452","source":"Crossref","is-referenced-by-count":32,"title":["Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathy"],"prefix":"10.1097","volume":"15","author":[{"given":"Andrew G","family":"Gianoukakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry J","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20211004","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/MED.0b013e3282ef1c48","article-title":"Environmental factors and genetic background that interact to cause autoimmune thyroid disease","volume":"14","author":"Guarneri","year":"2007","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"R2-11-20211004","first-page":"930","article-title":"Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts","volume":"86","author":"Brix","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-11-20211004","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/thy.2006.16.447","article-title":"Interaction of HLA-DRB1 alleles with CTLA-4 in the predisposition to Graves' disease: the impact of DRB1*07","volume":"16","author":"Kula","year":"2006","journal-title":"Thyroid"},{"key":"R4-11-20211004","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1146\/annurev.iy.12.040194.004313","article-title":"The CD40 antigen and its ligand","volume":"12","author":"Banchereau","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"R5-11-20211004","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1089\/thy.1999.9.749","article-title":"CD40 expression in human thyroid tissue: evidence for involvement of multiple cell types in autoimmune and neoplastic diseases","volume":"9","author":"Smith","year":"1999","journal-title":"Thyroid"},{"key":"R6-11-20211004","first-page":"1268","article-title":"Detection of CD40 on human thyroid follicular cells: analysis of expression and function","volume":"83","author":"Metcalfe","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-11-20211004","doi-asserted-by":"crossref","first-page":"C707","DOI":"10.1152\/ajpcell.1998.274.3.C707","article-title":"Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production","volume":"274","author":"Sempowski","year":"1998","journal-title":"Am J Physiol"},{"key":"R8-11-20211004","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1167\/iovs.05-0605","article-title":"Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy","volume":"46","author":"Feldon","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R9-11-20211004","doi-asserted-by":"crossref","first-page":"29615","DOI":"10.1074\/jbc.273.45.29615","article-title":"Activation of human orbital fibroblasts through CD40 engagement results in a dramatic induction of hyaluronan synthesis and prostaglandin endoperoxide H synthase-2 expression. Insights into potential pathogenic mechanisms of thyroid-associated ophthalmopathy","volume":"273","author":"Cao","year":"1998","journal-title":"J Biol Chem"},{"key":"R10-11-20211004","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1089\/105072502321085234","article-title":"A C\/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease","volume":"12","author":"Tomer","year":"2002","journal-title":"Thyroid"},{"key":"R11-11-20211004","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1089\/105072503322511319","article-title":"A C\/T polymorphism in the 5'-untranslated region of the CD40 gene is associated with Graves' disease in Koreans","volume":"13","author":"Kim","year":"2003","journal-title":"Thyroid"},{"key":"R12-11-20211004","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1507\/endocrj.52.471","article-title":"A C\/T polymorphism in the 5' untranslated region of the CD40 gene is associated with later onset of Graves' disease in Japanese","volume":"52","author":"Mukai","year":"2005","journal-title":"Endocr J"},{"key":"R13-11-20211004","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.gene.6364375","article-title":"A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression","volume":"8","author":"Jacobson","year":"2007","journal-title":"Genes Immun"},{"key":"R14-11-20211004","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1210\/en.2004-1617","article-title":"A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology","volume":"146","author":"Jacobson","year":"2005","journal-title":"Endocrinology"},{"key":"R15-11-20211004","first-page":"1035","article-title":"Ligation of CD40 induced tumor necrosis factor-alpha in rheumatoid arthritis: a novel mechanism of activation of synoviocytes","volume":"26","author":"Harigai","year":"1999","journal-title":"J Rheumatol"},{"key":"R16-11-20211004","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1073\/pnas.92.3.811","article-title":"CTLA4 mediates antigen-specific apoptosis of human T cells","volume":"92","author":"Gribben","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R17-11-20211004","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.270.5238.985","article-title":"Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4","volume":"270","author":"Waterhouse","year":"1995","journal-title":"Science"},{"key":"R18-11-20211004","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature01621","article-title":"Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease","volume":"423","author":"Ueda","year":"2003","journal-title":"Nature"},{"key":"R19-11-20211004","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/08916930500050319","article-title":"Association of a CTLA-4 3' untranslated region (CT60) single nucleotide polymorphism with autoimmune thyroid disease in the Japanese population","volume":"38","author":"Ban","year":"2005","journal-title":"Autoimmunity"},{"key":"R20-11-20211004","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1089\/thy.2005.15.232","article-title":"CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population","volume":"15","author":"Petrone","year":"2005","journal-title":"Thyroid"},{"key":"R21-11-20211004","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.humimm.2006.05.003","article-title":"CTLA4 polymorphisms and ophthalmopathy in Graves' disease patients: association study and meta-analysis","volume":"67","author":"Han","year":"2006","journal-title":"Hum Immunol"},{"key":"R22-11-20211004","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.gene.6364445","article-title":"Family-based association study of cytotoxic T-lymphocyte antigen-4 with susceptibility to Graves' disease in Han population of Taiwan","volume":"9","author":"Chen","year":"2008","journal-title":"Genes Immun"},{"key":"R23-11-20211004","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1210\/jc.2007-0147","article-title":"Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis","volume":"92","author":"Kavvoura","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R24-11-20211004","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1744-313X.2006.00614.x","article-title":"The common -318C\/T polymorphism in the promoter region of CTLA4 gene is associated with reduced risk of ophthalmopathy in Chinese Graves' patients","volume":"33","author":"Han","year":"2006","journal-title":"Int J Immunogenet"},{"key":"R25-11-20211004","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.clim.2007.01.003","article-title":"Soluble CTLA-4 in autoimmune thyroid diseases: relationship with clinical status and possible role in the immune response dysregulation","volume":"123","author":"Saverino","year":"2007","journal-title":"Clin Immunol"},{"key":"R26-11-20211004","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.2337\/diabetes.53.11.3020","article-title":"Replication of an association between the lymphoid tyrosine phosphatase locus (LYP\/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus","volume":"53","author":"Smyth","year":"2004","journal-title":"Diabetes"},{"key":"R27-11-20211004","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1210\/jc.2004-1108","article-title":"The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease","volume":"89","author":"Velaga","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R28-11-20211004","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1210\/jc.2006-2064","article-title":"Association of PTPN22 haplotypes with Graves' disease","volume":"92","author":"Heward","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-11-20211004","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1002\/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO;2-U","article-title":"Characterization of TCR-induced receptor-proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP","volume":"29","author":"Gjorloff-Wingren","year":"1999","journal-title":"Eur J Immunol"},{"key":"R30-11-20211004","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1084\/jem.189.1.111","article-title":"Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase","volume":"189","author":"Cloutier","year":"1999","journal-title":"J Exp Med"},{"key":"R31-11-20211004","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/ng1673","article-title":"Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant","volume":"37","author":"Vang","year":"2005","journal-title":"Nat Genet"},{"key":"R32-11-20211004","doi-asserted-by":"crossref","first-page":"19767","DOI":"10.1073\/pnas.0706233104","article-title":"Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases","volume":"104","author":"Yu","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R33-11-20211004","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1086\/426947","article-title":"Regression mapping of association between the human leukocyte antigen region and Graves disease","volume":"76","author":"Simmonds","year":"2005","journal-title":"Am J Hum Genet"},{"key":"R34-11-20211004","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4049\/jimmunol.175.1.575","article-title":"X chromosome monosomy: a common mechanism for autoimmune diseases","volume":"175","author":"Invernizzi","year":"2005","journal-title":"J Immunol"},{"key":"R35-11-20211004","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/sj.ejhg.5201614","article-title":"Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity","volume":"14","author":"Ozcelik","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"R36-11-20211004","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1196\/annals.1423.021","article-title":"Thyroid epigenetics: X chromosome inactivation in patients with autoimmune thyroid disease","volume":"1110","author":"Yin","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"R37-11-20211004","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1210\/jc.2005-1366","article-title":"High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity","volume":"90","author":"Brix","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R38-11-20211004","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2567.2007.02635.x","article-title":"Chronic exposure in vivo to thyrotropin receptor stimulating monoclonal antibodies sustains high thyroxine levels and thyroid hyperplasia in thyroid autoimmunity-prone HLA-DRB1*0301 transgenic mice","volume":"122","author":"Flynn","year":"2007","journal-title":"Immunology"},{"key":"R39-11-20211004","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1210\/en.2005-1031","article-title":"Differential requirement of signal transducer and activator of transcription-4 (Stat4) and Stat6 in a thyrotropin receptor-289-adenovirus-induced model of Graves' hyperthyroidism","volume":"147","author":"Land","year":"2006","journal-title":"Endocrinology"},{"key":"R40-11-20211004","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1210\/en.2006-1077","article-title":"An improved Graves' disease model established by using in vivo electroporation exhibited long-term immunity to hyperthyroidism in BALB\/c mice","volume":"148","author":"Kaneda","year":"2007","journal-title":"Endocrinology"},{"key":"R41-11-20211004","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1210\/en.2004-1015","article-title":"Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy","volume":"146","author":"Baker","year":"2005","journal-title":"Endocrinology"},{"key":"R42-11-20211004","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1210\/en.2007-1024","article-title":"The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells","volume":"148","author":"McLachlan","year":"2007","journal-title":"Endocrinology"},{"key":"R43-11-20211004","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.4049\/jimmunol.175.2.1310","article-title":"IL-1 beta induces IL-6 expression in human orbital fibroblasts: identification of an anatomic-site specific phenotypic attribute relevant to thyroid-associated ophthalmopathy","volume":"175","author":"Chen","year":"2005","journal-title":"J Immunol"},{"key":"R44-11-20211004","doi-asserted-by":"crossref","first-page":"18296","DOI":"10.1074\/jbc.M603484200","article-title":"Interleukin-4 induces 15-lipoxygenase-1 expression in human orbital fibroblasts from patients with Graves disease. Evidence for anatomic site-selective actions of Th2 cytokines","volume":"281","author":"Chen","year":"2006","journal-title":"J Biol Chem"},{"key":"R45-11-20211004","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.4049\/jimmunol.174.5.3072","article-title":"Induction by IL-1 beta of tissue inhibitor of metalloproteinase-1 in human orbital fibroblasts: modulation of gene promoter activity by IL-4 and IFN-gamma","volume":"174","author":"Han","year":"2005","journal-title":"J Immunol"},{"key":"R46-11-20211004","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1210\/en.2005-1375","article-title":"Immunoglobulin G from patients with Graves' disease induces interleukin-16 and RANTES expression in cultured human thyrocytes: a putative mechanism for T-cell infiltration of the thyroid in autoimmune disease","volume":"147","author":"Gianoukakis","year":"2006","journal-title":"Endocrinology"},{"key":"R47-11-20211004","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1210\/jcem.86.10.7953","article-title":"Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes","volume":"86","author":"Garcia-Lopez","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R48-11-20211004","doi-asserted-by":"crossref","first-page":"942","DOI":"10.4049\/jimmunol.168.2.942","article-title":"Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts","volume":"168","author":"Pritchard","year":"2002","journal-title":"J Immunol"},{"key":"R49-11-20211004","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1210\/jc.2005-1689","article-title":"Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists","volume":"91","author":"Antonelli","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R50-11-20211004","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0002-9440(10)64171-5","article-title":"Expression of IP-10\/CXCL10 and MIG\/CXCL9 in the thyroid and increased levels of IP-10\/CXCL10 in the serum of patients with recent-onset Graves' disease","volume":"161","author":"Romagnani","year":"2002","journal-title":"Am J Pathol"},{"key":"R51-11-20211004","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1530\/eje.1.02137","article-title":"Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process","volume":"154","author":"Antonelli","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"R52-11-20211004","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1677\/JOE-07-0240","article-title":"Methimazole inhibits CXC chemokine ligand 10 secretion in human thyrocytes","volume":"195","author":"Crescioli","year":"2007","journal-title":"J Endocrinol"},{"key":"R53-11-20211004","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.4049\/jimmunol.170.12.6348","article-title":"Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway","volume":"170","author":"Pritchard","year":"2003","journal-title":"J Immunol"},{"key":"R54-11-20211004","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.4049\/jimmunol.178.5.3281","article-title":"Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis","volume":"178","author":"Douglas","year":"2007","journal-title":"J Immunol"},{"key":"R55-11-20211004","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/eje.1.01892","article-title":"CXCR6 within T-helper (Th) and T-cytotoxic (Tc) type 1 lymphocytes in Graves' disease (GD)","volume":"152","author":"Aust","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"R56-11-20211004","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.4049\/jimmunol.174.6.3773","article-title":"CD1a and CD1c activate intrathyroidal T cells during Graves' disease and Hashimoto's thyroiditis","volume":"174","author":"Roura-Mir","year":"2005","journal-title":"J Immunol"},{"key":"R57-11-20211004","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/105072502753600124","article-title":"Thyrotropin receptor expression in orbital adipose\/connective tissues from patients with thyroid-associated ophthalmopathy","volume":"12","author":"Bahn","year":"2002","journal-title":"Thyroid"},{"key":"R58-11-20211004","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0140-6736(93)91475-2","article-title":"Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue","volume":"342","author":"Feliciello","year":"1993","journal-title":"Lancet"},{"key":"R59-11-20211004","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1167\/iovs.06-0596","article-title":"Biological effects of thyrotropin receptor activation on human orbital preadipocytes","volume":"47","author":"Zhang","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R60-11-20211004","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1530\/eje.1.01900","article-title":"Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation","volume":"152","author":"Agretti","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"R61-11-20211004","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2353\/ajpath.2006.060434","article-title":"Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes","volume":"169","author":"Feldon","year":"2006","journal-title":"Am J Pathol"},{"key":"R62-11-20211004","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1210\/jc.2004-2239","article-title":"Gene expression profiling of orbital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adipogenesis","volume":"90","author":"Kumar","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R63-11-20211004","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1210\/jc.2006-2388","article-title":"B lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study","volume":"92","author":"El Fassi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R64-11-20211004","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1530\/eje.1.02325","article-title":"Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study","volume":"156","author":"Salvi","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"R65-11-20211004","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/thy.1996.6.381","article-title":"The effect of somatostatin versus corticosteroid in the treatment of Graves' ophthalmopathy","volume":"6","author":"Kung","year":"1996","journal-title":"Thyroid"},{"key":"R66-11-20211004","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1210\/jc.2004-0697","article-title":"Double-blind, placebo-controlled trial of octreotide long-acting repeatable (LAR) in thyroid-associated ophthalmopathy","volume":"89","author":"Dickinson","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R67-11-20211004","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1210\/jc.2004-1334","article-title":"Octreotide (long-acting release formulation) treatment in patients with graves' orbitopathy: clinical results of a four-month, randomized, placebo-controlled, double-blind study","volume":"90","author":"Wemeau","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R68-11-20211004","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1210\/jc.2006-1105","article-title":"Randomized, double-blind, placebo-controlled trial of long-acting release octreotide for treatment of Graves' ophthalmopathy","volume":"91","author":"Stan","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R69-11-20211004","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF03344124","article-title":"Slow-release lanreotide in Graves' ophthalmopathy: a double-blind randomized, placebo-controlled clinical trial","volume":"29","author":"Chang","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"R70-11-20211004","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2362.1993.tb00712.x","article-title":"Detection and localization of cytokine immunoreactivity in retro-ocular connective tissue in Graves' ophthalmopathy","volume":"23","author":"Heufelder","year":"1993","journal-title":"Eur J Clin Invest"},{"key":"R71-11-20211004","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1210\/jc.2003-030380","article-title":"Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with graves' ophthalmopathy","volume":"88","author":"Kumar","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R72-11-20211004","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/sj.gene.6364066","article-title":"A systematic approach to the assessment of known TNF-alpha polymorphisms in Graves' disease","volume":"5","author":"Simmonds","year":"2004","journal-title":"Genes Immun"},{"key":"R73-11-20211004","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.clinbiochem.2006.11.009","article-title":"Cytokine promoter polymorphisms in Taiwanese patients with Graves' disease","volume":"40","author":"Shiau","year":"2007","journal-title":"Clin Biochem"},{"key":"R74-11-20211004","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-3083.2006.01830.x","article-title":"Dysregulation of TNF\/TNFR superfamily members: a systemic link between intra- and extrathyroidal manifestations in Graves' disease","volume":"64","author":"Quadbeck","year":"2006","journal-title":"Scand J Immunol"},{"key":"R75-11-20211004","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/sj.eye.6701768","article-title":"The effect of etanercept on Graves' ophthalmopathy: a pilot study","volume":"19","author":"Paridaens","year":"2005","journal-title":"Eye"},{"key":"R76-11-20211004","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/01676830590912562","article-title":"Infliximab: a novel treatment for sight-threatening thyroid associated ophthalmopathy","volume":"24","author":"Durrani","year":"2005","journal-title":"Orbit"}],"container-title":["Current Opinion in Endocrinology, Diabetes &amp; Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01266029-200810000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:47:51Z","timestamp":1786042071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01266029-200810000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":76,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0b013e32830eb8ab","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}